Search research articles
Contact Us
Filters
Showing results (121-130 of 135) with videos related to
Page
of 14
Sort By:
Molecular Cancer Therapeutics
|
August 19, 2016
Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Stefan Stremitzer, Wu Zhang, Dongyun Yang, et al.
Cancer
|
July 15, 2017
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
Satoshi Okazaki, Marta Schirripa, Fotios Loupakis, et al.
Stem Cells (Dayton, Ohio)
|
February 27, 2007
Analyses of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes
Qing Li, Hiroko Hisha, Ryoji Yasumizu, et al.
International Journal of Cancer
|
April 4, 2017
Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial
Marta Schirripa, Wu Zhang, Volker Heinemann, et al.
Frontiers in Psychiatry
|
March 13, 2024
Association of <i>SLC6A3</i> variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia
Masanobu Kogure, Nobuhisa Kanahara, Atsuhiro Miyazawa, et al.
International Journal of Cancer
|
June 2, 2017
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer
Satoshi Okazaki, Sebastian Stintzing, Yu Sunakawa, et al.
Clinical Colorectal Cancer
|
April 3, 2018
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2017
A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab
Martin D Berger, Sebastian Stintzing, Volker Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2017
Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials
Martin D Berger, Shinichi Yamauchi, Shu Cao, et al.
The Pharmacogenomics Journal
|
June 22, 2018
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 135) with videos related to
Sort By:
Page
of 14
Molecular Cancer Therapeutics
|
August 19, 2016
Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Stefan Stremitzer, Wu Zhang, Dongyun Yang, et al.
Cancer
|
July 15, 2017
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
Satoshi Okazaki, Marta Schirripa, Fotios Loupakis, et al.
Stem Cells (Dayton, Ohio)
|
February 27, 2007
Analyses of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes
Qing Li, Hiroko Hisha, Ryoji Yasumizu, et al.
International Journal of Cancer
|
April 4, 2017
Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial
Marta Schirripa, Wu Zhang, Volker Heinemann, et al.
Frontiers in Psychiatry
|
March 13, 2024
Association of <i>SLC6A3</i> variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia
Masanobu Kogure, Nobuhisa Kanahara, Atsuhiro Miyazawa, et al.
International Journal of Cancer
|
June 2, 2017
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer
Satoshi Okazaki, Sebastian Stintzing, Yu Sunakawa, et al.
Clinical Colorectal Cancer
|
April 3, 2018
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2017
A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab
Martin D Berger, Sebastian Stintzing, Volker Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2017
Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials
Martin D Berger, Shinichi Yamauchi, Shu Cao, et al.
The Pharmacogenomics Journal
|
June 22, 2018
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Page
of 14